Introduction

  • 1  Jemec GB, Nybaek H. Peristomal skin problems account for more than one in three visits to ostomy nurses. Br J Dermatol 2008;159(5):121112. Pubmed link
  • 2  Lyon CC, Smith AD, Griffiths CE, Beck MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol 2000;143(6):124860. Cross Ref link Pubmed link
  • 3  Al‐Niaimi F, Almaani N, Samarasinghe V, Williams J, Lyon C. The relevance of patch testing in peristomal dermatitis. Br J Dermatol 2012;167:1039. Cross Ref link Pubmed link

Allergic contact dermatitis

  • 4  Al‐Niaimi F, Almaani N, Samarasinghe V, Williams J, Lyon C. The relevance of patch testing in peristomal dermatitis. Br J Dermatol 2012;167:1039. Cross Ref link Pubmed link
  • 5  Martin JA, Hughes TM, Stone NM. Peristomal allergic contact dermatitis – case report and review of the literature. Contact Dermatitis 2005;52(5):2735. Cross Ref link Pubmed link

Infections

  • 6  Lyon CC, Smith AD, Griffiths CE, Beck MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol 2000;143(6):124860. Cross Ref link Pubmed link
  • 7  Smith AJ, Lyon CC, Hart CA. Multidisciplinary care of skin problems in stoma patients. Br J Nurs 2002;11(5):32430. Cross Ref link Pubmed link

Other skin conditions presenting near stomas

  • 8  Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982;106(3):32330. Cross Ref link Pubmed link
  • 9  Lyon CC, Smith AD, Griffiths CE, Beck MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol 2000;143(6):124860. Cross Ref link Pubmed link
  • 10  AH‐Weng A, Charles‐Holmes R. Peristomal lichen sclerosus affecting colostomy sites. Br J Dermatol 2000;142(1):1778. Cross Ref link Pubmed link
  • 11  Farrar CW, Dowling P, Mendelsohn SD. Peristomal lichen sclerosus developing posturostomy. Clin Exp Dermatol 2003;28(2):2234. Cross Ref link Pubmed link
  • 12  Al‐Niaimi F, Lyon C. Peristomal lichen sclerosus: the role of occlusion and urine exposure? Br J Dermatol 2013;168(3):6436. Cross Ref link Pubmed link
  • 13  Boulinguez S, Bedane C, Bouyssou Gauthier ML, et al. [Giant buccal aphthosis caused by nicorandil]. Presse Med 1997;26(12):558. Pubmed link
  • 14  Watson A, Al Ozairi O, Fraxer A, et al. Nicorandil associated anal ulceration. Lancet 2002;360(9332):5467. Cross Ref link Pubmed link
  • 15  Ogden S, Mukasa Y, Lyon CC, Coulson IH. Nicorandil‐induced peristomal ulcers: is nicorandil also associated with gastrointestinal fistula formation? Br J Dermatol 2007;156(3):6089. Cross Ref link Pubmed link
  • 16  King PM, Suttie SA, Jansen JO, Watson AJ. Perforation of the terminal ileum: a possible complication of nicorandil therapy. Surgeon 2004;2(1):567. Cross Ref link Pubmed link
  • 17  Smith VM, Lyon CC. Nicorandil: do the dermatological and gastrointestinal risks outweigh the benefits? Br J Dermatol 2012;167(5):104852. Cross Ref link Pubmed link
  • 18  McDaid J, Reichl C, Hamzah I, et al. Diverticular fistulation is associated with nicorandil usage. Ann R Coll Surg Engl 2010;92(6):4635. Cross Ref link Pubmed link
  • 19  Felton S, Al‐Niaimi F, Lyon C. Peristomal and generalized bullous pemphigoid in patients with underlying inflammatory bowel disease: is plectin the missing link? Ostomy Wound Manage 2013;58(12):348.
  • 20  Griffiths CE, Tranfaglia MG, Kang S. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. J Am Acad Dermatol, 1995;32(4):61822. Cross Ref link Pubmed link

Dermatoses associated with underlying bowel disease

  • 21  Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000;42(6):9921002. Cross Ref link Pubmed link
  • 22  Kiran RP, O'Brien‐Ermlich B, Achkar JP, Fazio VW, Delaney CP.Management of peristomal pyoderma gangrenosum. Dis Colon Rectum 2005;48(7):1397403. Cross Ref link Pubmed link
  • 23  Cairns BA, Herbst CA, Sartor BR, Briggaman RA, Koruda MJ. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg 1994;129(7):76972. Cross Ref link Pubmed link
  • 24  Tjandra JJ, Hughes LE. Parastomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 1994;37(9):93842. Cross Ref link Pubmed link
  • 25  Sheldon DG, Sawchuk LL, Kozarek RA, Thirlby RC. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management. Arch Surg 2000;135(5):5648; discussion 568–9. Cross Ref link Pubmed link
  • 26  Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 2000;284(12):15468. Cross Ref link Pubmed link
  • 27  Lyon CC. Ten years experience running a stoma care dermatology clinic. Presented at 10th ECET Congress, Porto, Portugal, 2009.
  • 28  Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55(217):17386. Pubmed link
  • 29  Nybaek H, Olsen AG, Karlsmark T, Jemec GB. Topical therapy for peristomal pyoderma gangrenosum. J Cutan Med Surg 2004;8(4):2203. Cross Ref link Pubmed link
  • 30  Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat 2001;12(1):1317. Cross Ref link Pubmed link
  • 31  Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006;55(4):5059. Cross Ref link Pubmed link

Irritant skin reactions

  • 32  Herlufsen P, Olsen AG, Carlsen B, et al. Study of peristomal skin disorders in patients with permanent stomas. Br J Nurs 2006;15(16):85462. Cross Ref link Pubmed link
  • 33  Lyon CC, Smith AD, Griffiths CE, Beck MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol 2000;143(6):124860. Cross Ref link Pubmed link
  • 34  Williams JL, Lyon C. Dermatitis: contact allergy and contact irritation. In: Lyon CC, Smith AJ, eds. Abdominal Stomas and their Skin Disorders, 2nd edn. London: Informa Healthcare, 2010:5286.
  • 35  Omura Y, Yamabe M, Anazawa S. Peristomal skin disorders in patients with intestinal and urinary ostomies: influence of adhesive forces of various hydrocolloid wafer skin barriers. J Wound Ostomy Continence Nurs 2010;37(3):28998. Cross Ref link Pubmed link
  • 36  Lyon CC. Papular over granulation with bowel metaplasia. Br J Dermatol 2000;143(Suppl. 57):83. Cross Ref link
  • 37  Al‐Niaimi F, Lyon CC. Primary adenocarcinoma in peristomal skin: a case study. Ostomy Wound Manage 2010;56(1):457. Pubmed link
  • 38  Bergman BFK, Lincoln K, Lowhagen GB, Mobacken H, Wahlen P. Chronic papillomatous dermatitis as a peristomal complication in conduit urinary diversion. Scand J Urol Nephrol 1979;13:20114. Cross Ref link Pubmed link
  • 39  Jeter KF, Lattimer JK. Common stomal problems following ideal conduit urinary diversion. Recognition and treatment. Urology 1974;3(4):399403.
  • 40  Tanaka H, Arai K, Fujino A, et al. Treatment for hypergranulation at gastrostomy sites with sprinkling salt in paediatric patients. J Wound Care 2013;22(1):1718, 20. Cross Ref link Pubmed link